Skip to main content

Table 1 Patient characteristics at baseline

From: Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

Parameters Mean ± SE
Age (years) 65.4 ± 1.9
Male/female 15:20
Duration of diabetes (years) 20.1 ± 1.8
Duration of HD (years) 3.5 ± 0.4
Before treatment (n) None: 7
α-Glucosidase inhibitors: 5
Sulfonylureas: 2
Vildagliptin: 2
Alogliptin: 2
Liraglutide: 4
Insulin: 13
Statins: 9
  1. HD, hemodialysis